Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
The annual meeting of the stockholders of ClearPoint Neuro, Inc. (the "Company") was held on May 15, 2024 (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted to approve the adoption of the ClearPoint Neuro, Inc. Fifth Amended and Restated 2013 Incentive Compensation Plan (the "Plan"). The Company's Board of Directors had previously adopted and approved the Plan, subject to stockholder approval. A description of the terms and conditions of the Plan is set forth in the Company's 2024 Proxy Statement, filed with the Securities and Exchange Commission on April 5, 2024 (the "Proxy Statement") under "Proposal 4 - Approval of the Fifth Amended and Restated 2013 Incentive Compensation Plan," and such description is incorporated herein by reference. The descriptions set forth herein and in the Proxy Statement are summaries and are qualified in their entirety by the full text of the Plan, a copy of which is incorporated by reference to Exhibit 10.1 to this Current Report on Form 8-K.